DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Tamaskar I, Garcia JA, Elson P, Wood L, Mekhail T, Dreicer R, Rini BI, Bukowski RM.
Antitumor effects of sunitinib or sorafenib in patients with
metastatic renal cell carcinoma who received prior antiangiogenic therapy.
J Urol 2008; 179: 81-86
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.